Serological Study of the Exposure of Personnel to COVID-19 (SEROPHUGAC)

Centre Hospitalier Saint Joseph Saint Luc de Lyon

Status: Completed

Conditions: Sars-CoV2

Treatments: Diagnostic Test: Sars-Cov-2 serology

Study type: Interventional

Funder types: Other

Identifiers

NCT04422977

SEROPHUGAC

Details and patient eligibility

About

A seroconversion test for SARS-Cov-2 will be offered to all the employees of a care institution, which has treated 240 patients hospitalized for COVID disease between 28/02 and 30/04/2020. The seroconversion test will be with a questionnaire to determine:

• whether the subject has shown signs of infection in the last 3 recent months
• if the subject has been in contact with COVID-diagnosed subjects (RT-PCR diagnosis or scanner) outside of the activity or within the professional activity (patient or colleague)
• Working conditions during the period
• The level of knowledge and respect of the barrier measures practices.
• Respect for distance during meals professional. Overall seroprevalence and stratified seroprevalence by care and administrative areas will be determined.

Enrollment: 957 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Subject who worked at Saint Joseph Saint Luke's Hospital during the epidemic wave (male or female).

  • Free and informed consent
  • Social security affiliation

Exclusion criteria

• Subject refusal
• Subject on leave during the entire period

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

957 participants in 1 patient group

CoVID exposure

Other group

Treatment:

Diagnostic Test: Sars-Cov-2 serology